Furthermore, the constitutive activation of nuclear factor-κB (NF-κB) and bone marrow stromal cell-induced NF-κB activation are involved in bortezomib resistance in MM cells and primary MM cells [16,17]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.